Journey Medical (DERM): מחיר למכירות

Steady demand for approved dermatological brands at Journey Medical (DERM) ensures sustainable revenue, as reflected in the company's P/S ratio dynamics, where the indicator reaches 1.40. The optimization of regional warehouses supports retail profitability by preventing drug shortages. Simultaneously, the business minimizes its environmental footprint through plastic recycling and strict compliance with waste disposal regulations.

The operating model of Journey Medical (DERM) is reflected in the shifting P/S multiple amid geopolitical risks and substance supply chain disruptions. This indicator compares market capitalization to annual revenue, allowing investors to assess the premium paid for the asset and the business value's sensitivity to external shocks, excluding debt load or accounting distortions.